Abivax Drug Shows Promise but Cancer Risk

3 stories

June 2

STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting
statnews.com · Jun 2
Abivax: M&A Premium Vanishes After Obefazimod Phase 3 Safety Signal
Seeking Alpha · Jun 2

June 1

STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns
statnews.com · Jun 1

Abivax Drug Shows Promise but Cancer Risk | Clustered News